IGEA Pharma NV
F:3B5
IGEA Pharma NV
F:3B5
Price:
16.791
EUR
-3.07%
Market Closed
Market Cap:
€10.6m
Balance Sheet
Balance Sheet Decomposition
IGEA Pharma NV
IGEA Pharma NV
Balance Sheet Decomposition is not available for
IGEA Pharma NV
IGEA Pharma NV
Balance Sheet
IGEA Pharma NV
IGEA Pharma NV
Currency: EUR
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
0
|
0
|
3
|
1
|
0
|
1
|
0
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
1
|
0
|
0
|
0
|
0
|
0
|
9
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Total Assets |
1
N/A
|
1
+18%
|
1
-13%
|
3
+427%
|
1
-69%
|
1
-32%
|
11
+1 539%
|
0
-98%
|
|
| Liabilities | |||||||||
| Accounts Payable |
0
|
0
|
0
|
1
|
0
|
0
|
1
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
0
|
1
|
1
|
0
|
2
|
1
|
|
| Long-Term Debt |
0
|
1
|
1
|
0
|
0
|
0
|
1
|
1
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
1
N/A
|
1
+61%
|
1
-3%
|
1
-32%
|
0
-45%
|
0
+2%
|
2
+334%
|
3
+18%
|
|
| Equity | |||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
3
|
3
|
|
| Retained Earnings |
0
|
1
|
1
|
2
|
0
|
0
|
10
|
22
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
0
|
16
|
16
|
|
| Total Equity |
0
N/A
|
1
-186%
|
1
-9%
|
2
N/A
|
1
-78%
|
0
-62%
|
9
+4 383%
|
2
N/A
|
|
| Total Liabilities & Equity |
1
N/A
|
1
+18%
|
1
-13%
|
3
+427%
|
1
-69%
|
1
-32%
|
11
+1 539%
|
0
-98%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
25
|
25
|
25
|
25
|
25
|
25
|
334
|
337
|
|
Switch to:
Switch to:
See Also
Discover More
